2013/2017 H7N9 Prime-Boost Interval
Clinical trial NCT03589807 · COMPLETED
Trial details
- NCT number
- NCT03589807
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-21
- Primary completion
- 2020-06-14
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.